Biscayne NeuroTherapeutics
Biscayne Pharmaceuticals discovers and develops novel therapies based on growth hormone-releasing hormone (GHRH) analogs.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD252m (Public information from Sep 2018)
Miami Florida (HQ)
Authorizing premium user...